3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
7
Metastatic Castration-resistant Prostate Cancer
2
Prostatic Neoplasms, Castration-Resistant
1
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
1
Kidney Neoplasms
1
Glioma
1
Glioblastoma
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma
1
Astrocytoma
1
Interventions
Prednisone
4
Docetaxel
4
enzalutamide
2
olaparib
1
niraparib
1
ibrutinib
1
fludrocortisone acetate
1
darolutamide
1
cabazitaxel
1
abiraterone
1
Rosuvastatin Calcium
1
Pluvicto
1
Pioglitazone
1
JNJ-64619178
1
JNJ-64264681
1
Dexamethasone
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms, Castration-Resistant
×
Pluvicto
×
30 days
×
Clear all
NCT07587814
2026-05-14
COCORIVO
Centre Henri Becquerel
Phase NA
Not yet recruiting
100 enrolled